BET bromodomain inhibitors synergize with ATR inhibitors in melanoma

Metastatic malignant melanoma continues to be a challenging disease despite clinical translation of the comprehensive understanding of driver mutations and how melanoma cells evade immune attack. In Myc-driven lymphoma, efficacy of epigenetic inhibitors of the bromodomain and extra-terminal domain (...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cell Death Dis
मुख्य लेखकों: Muralidharan, Somsundar Veppil, Einarsdottir, Berglind Osk, Bhadury, Joydeep, Lindberg, Mattias F, Wu, Jin, Campeau, Eric, Bagge, Roger Olofsson, Stierner, Ulrika, Ny, Lars, Nilsson, Lisa M, Nilsson, Jonas A
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group 2017
विषय:
Original Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5596569/
https://ncbi.nlm.nih.gov/pubmed/28796244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2017.383
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन